Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blueberry leaf extract is a botanical extract derived from the leaves of the blueberry plant, most commonly *Vaccinium corymbosum*. It is characterized by a high concentration of polyphenolic compounds, such as chlorogenic acid and various flavonoids, which are believed to be responsible for its metabolic effects. In preclinical studies, the extract has demonstrated the ability to significantly reduce body weight gain, adipose tissue weight, and liver lipid accumulation in subjects fed high-fat, high-sucrose diets. The mechanism involves the inhibition of body fat accumulation and the reduction of adipocyte size, likely through the modulation of lipid metabolism pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on blueberry leaf extract.